Making a Bet on Big Pharma

Nicholas Vardy

Nicholas Vardy has a unique background that has proven his knack for making money in different markets around the world.

This week’s Alpha Algorithm hones in on yet another steady-dividend-paying stock, typical of the stocks that have been outperforming the broader stock market in this range-bound year. The stock’s pullback over the past few days offers a particularly good entry point.

Incorporated in 2012 and based in North Chicago, Illinois, AbbVie Inc. (ABBV) is one of the nation’s largest pharmaceutical companies. The company’s three most important drugs on the market today are Humira (rheumatoid arthritis), Imbruvica (cancer) and Viekira Pak (Hepatitis C).

AbbVie started its corporate life as a spin-off of Abbott Laboratories (ABT), whose dividend history is included in AbbVie’s for the purposes of the Alpha Algorithm strategies.

abbv

                          AbbVie Inc. (ABBV) vs. the S&P 500 YTD

Six Top Investment Strategies Betting on AbbVie Inc. (ABBV)

  1.  Dividend Aristocrat

The stock is among those in the S&P 500 that have increased dividends for at least 25 consecutive years.

  1. Dividend Dogs

One of the five highest-yielding stocks among each of the 10 sectors tracked in the S&P 500.

  1. High and Steady Dividend

The stock is one of 50 dividend-paying companies from the S&P 1,500 Composite Index that has increased dividends for at least 20 consecutive years.

  1. Small-Cap/Value Tilt

Selected using a multi-factor modeling approach, the stock is a smaller-cap or value stock designed to enhance portfolio risk/return characteristics.

  1. IPO Index

This strategy tracks a market-cap-weighted index of the 100 largest U.S. initial public offerings (IPOs) over the first 1,000 trading days of each stock. Stocks must pass additional quantitative screens as well.

  1. Spin-Offs

The company has spun away from its parent firm in the last four years. Spin-offs have a solid history of outperforming the broader market.

Exclusive  Waiting For the Other Shoe to Drop...

Recommendation

Buy AbbVie Inc. (ABBV) at market today. Place your initial stop at $54.

Options

With the stock currently in a technical correction. I am holding off on recommending options this week.

Portfolio Update

With the Autozone (AZO) stock now included in only three of the original seven Alpha Algorithm strategies, it is time to say good-bye to this position at a slight loss of 2.13%. Remember to sell your related option positions as well.

Sincerely,

Nicholas Vardy

Like This Article?
Now Get Our FREE Special Report:
Alternative Investing: Investing in Timber

Stock Investor editor Paul Dykewicz reveals why investing in timber may be one of the best long-term portfolio strategies you'll find today.

Get Access to the Report, 100% FREE


img
previous article

It was a relatively quiet week for U.S. stock markets, with the Dow Jones up 0.85%, S&P 500 rising 0.72% and the NASDAQ eking out a 0.28% gain. The MCSI Emerging Markets Index, in contrast, jumped an impressive 4.32%. Big gainers in your Alpha Investor Letter portfolio included the iShares MSCI Philippines (EPHE), which rocketed 6.10% higher, BYD Company, Ltd. (BYDDF), which rose 4.65%, and the Cambria Global Value ETF (GVAL), whic

PREMIUM SERVICES FOR INVESTORS

Dr. Mark Skousen

Named one of the "Top 20 Living Economists," Dr. Skousen is a professional economist, investment expert, university professor, and author of more than 25 books.

Product Details

LEARN MORE HERE

Bryan Perry

A former Wall Street financial advisor with three decades' experience, Bryan Perry focuses his efforts on high-yield income investing and quick-hitting options plays.

Product Details

LEARN MORE HERE

Jim Woods

Jim Woods has over 20 years of experience in the markets from working as a stockbroker,
financial journalist, and money manager. As well as a book author and regular contributor to
numerous investment websites, Jim is the editor of:

Product Details

LEARN MORE HERE

Bob Carlson

Bob Carlson provides independent, objective research covering all the financial issues of retirement and retirement planning. In addition, Bob serves as Chairman of the Board of Trustees of the Fairfax County (VA) Employees’ Retirement System, which has over $2.8 billion in assets.

Product Details

LEARN MORE HERE

Mike Turner

Mike Turner’s financial, mathematical, computer science and engineering background serves as the foundation for his disciplined, rules-based approach to trading. Mike’s three services include:

Product Details

LEARN MORE HERE

Hilary Kramer

Hilary Kramer is an investment analyst and portfolio manager with 30 years of experience on Wall Street. Since 2010, Hilary's financial publications have provided stock analysis and investment advice to her subscribers:

Product Details

LEARN MORE HERE

DividendInvestor.com

Used by financial advisors and individual investors all over the world, DividendInvestor.com is the premier provider and one-stop shop for dividend information and research.

Product Details

Popular tools include our proprietary Dividend Calendar, Dividend Calculator, Dividend Score Card, and many more.

LEARN MORE HERE